54192EGP
- Active ingredient
- dupilumab
- Strength
- 200 mg
- Form
- syringe
- Manufacturer
- sanofi > sanofi scientific office
- Route
- injection
Uses
Used for moderate-to-severe atopic dermatitis, certain forms of asthma, chronic rhinosinusitis with nasal polyps, and other type 2 inflammatory diseases.
Do not use if
Contraindicated in patients with known hypersensitivity to dupilumab or its excipients.
Side effects
May cause injection-site reactions, conjunctivitis, keratitis, arthralgia, and hypersensitivity reactions.
Warnings
Serious hypersensitivity reactions can occur. Monitor for ocular complications and parasitic infections.
How it works
A monoclonal antibody that inhibits IL-4 and IL-13 signaling by targeting the IL-4 receptor alpha subunit.
Storage
Store refrigerated at 2–8°C in the original carton and protect from light.
